Consistent with previous findings, CellChat analysis indicated that HLA-E-positive cancer cells can regulate NK cell function through the binding of inhibitory receptors CD94/NKG2E via HLA-E in all subsets of NK cells (CD56+CD16−, CD56+CD16+, and CD56−CD16+) (Figure 7B). Here, KLRC3 is linked to cancer.